Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study

Author:

Majiya HussainiORCID,Aliyu-Paiko MohammedORCID,Balogu Vincent TochukwuORCID,Musa Dickson AchimuguORCID,Salihu Ibrahim MaikudiORCID,Kawu Abdullahi AbubakarORCID,Bashir Ishaku YakubuORCID,Sani Aishat RabiuORCID,Baba JohnORCID,Muhammad Amina TakoORCID,Jibril Fatimah LadidiORCID,Bala EzekielORCID,Obaje Nuhu GeorgeORCID,Aliyu Yahaya BadeggiORCID,Muhammad Ramatu GogoORCID,Mohammed HadizaORCID,Gimba Usman NajiORCID,Uthman AbduljeliliORCID,Liman Hadiza MuhammadORCID,Alhaji Sule AlfaORCID,James Joseph KoloORCID,Makusidi Muhammad MuhammadORCID,Isah Mohammed DanasabeORCID,Abdullahi IbrahimORCID,Ndagi UmarORCID,Waziri BalaORCID,Bisallah Chindo IbrahimORCID,Dadi-Mamud Naomi JohnORCID,Ibrahim KoloORCID,Adamu Abu KasimORCID

Abstract

Abstract Background The COVID-19 pandemic caused by SARS-CoV-2 is causing ongoing human and socioeconomic losses. Objective To know how far the virus has spread in Niger State, Nigeria, a pilot study was carried out to determine the SARS-CoV-2 seroprevalence, patterns, dynamics, and risk factors in the state. Methods A cross-sectional study design and clustered, stratified random sampling strategy were used to select 185 test participants across the state. SARS-CoV-2 IgG and IgM rapid test kits (colloidal gold immunochromatography lateral flow system) were used to determine the presence or absence of antibodies to the virus in the blood of sampled participants across Niger State from June 26 to 30, 2020. The test kits were validated using the blood samples of some of the Nigeria Center for Disease Control–confirmed positive and negative COVID-19 cases in the state. SARS-CoV-2 IgG and IgM test results were entered into the Epi Info questionnaire administered simultaneously with each test. Epi Info was then used to calculate the arithmetic mean and percentage, odds ratio, χ2 statistic, and regression at a 95% CI of the data generated. Results The seroprevalence of SARS-CoV-2 in Niger State was found to be 25.4% (47/185) and 2.2% (4/185) for the positive IgG and IgM results, respectively. Seroprevalence among age groups, genders, and occupations varied widely. The COVID-19 asymptomatic rate in the state was found to be 46.8% (22/47). The risk analyses showed that the chances of infection are almost the same for both urban and rural dwellers in the state. However, health care workers, those who experienced flulike symptoms, and those who had contact with a person who traveled out of Nigeria in the last 6 months (February to June 2020) were at double the risk of being infected with the virus. More than half (101/185, 54.6%) of the participants in this study did not practice social distancing at any time since the pandemic started. Participants’ knowledge, attitudes, and practices regarding COVID-19 are also discussed. Conclusions The observed Niger State SARS-CoV-2 seroprevalence and infection patterns meansuggest that the virus has widely spread, far more SARS-CoV-2 infections have occurred than the reported cases, and there is a high asymptomatic COVID-19 rate across the state.

Publisher

JMIR Publications Inc.

Subject

Pharmaceutical Science

Reference27 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3